9.16 USD
+0.05 (+0.55%)
9.16 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 71% to CCRN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 11.68. This target is 27.52% above the current price.
- CCRN was analyzed by 14 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about CCRN.
- In the last month the buy percentage rose by 19 points. So the trust of analysts is improving.
- CCRN was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-09 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-17 | Barrington Research | Maintains | Market Perform -> Market Perform |
| 2025-05-13 | UBS | Maintains | Neutral -> Neutral |
| 2025-03-14 | Barrington Research | Maintains | Market Perform -> Market Perform |
| 2025-02-06 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2024-12-10 | Barrington Research | Downgrade | Outperform -> Market Perform |
| 2024-12-05 | Truist Securities | Maintains | Hold -> Hold |
| 2024-11-07 | Benchmark | Maintains | Buy -> Buy |
| 2024-10-21 | Truist Securities | Maintains | Hold -> Hold |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-01 | Truist Securities | Maintains | Hold -> Hold |
| 2024-05-06 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-02 | Benchmark | Maintains | Buy -> Buy |
| 2024-02-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-22 | Benchmark | Maintains | Buy -> Buy |
| 2024-02-22 | Truist Securities | Maintains | Hold -> Hold |
| 2023-12-06 | JMP Securities | Initiate | Market Perform |
| 2023-11-30 | UBS | Initiate | Neutral |
| 2023-11-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-11-03 | Truist Securities | Maintains | Hold -> Hold |
| 2023-11-03 | Jefferies | Downgrade | Buy -> Hold |
| 2023-10-05 | Jefferies | Maintains | Buy -> Buy |
| 2023-08-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-08-08 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-06-26 | William Blair | Initiate | Outperform |
| 2023-06-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-05-05 | Credit Suisse | Maintains | Neutral |
| 2023-05-02 | Truist Securities | Maintains | Hold |
| 2023-03-10 | Loop Capital | Initiate | Buy |
| 2023-02-23 | Benchmark | Maintains | Buy |
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the average price target for CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
14 analysts have analysed CCRN and the average price target is 11.68 USD. This implies a price increase of 27.52% is expected in the next year compared to the current price of 9.16.
What is the consensus rating for CCRN stock?
The consensus rating for CROSS COUNTRY HEALTHCARE INC (CCRN) is 71.4286 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed CROSS COUNTRY HEALTHCARE INC (CCRN)?
The number of analysts covering CROSS COUNTRY HEALTHCARE INC (CCRN) is 14.